Information Library

Results for: Consulting - Market Access

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Quintiles Backs Change to Marketing Mix as NHS Reforms Take Hold

    Press Release — READING, UK – 30 May, 2012 – Quintiles has released the first in a series of briefing papers looking at how market access strategies can

  • UK Market Access Insight Brief

    White Paper — May 30, 2012
    Insight Briefing series on Market Access in key European countries

  • UK Market Access Insight Brief

    Hear from the Experts — May 30, 2012
    Quintiles' Robert Taylor and Gareth Williams discuss the impact of healthcare reform on commercialisation strategy for the UK.

  • UK Market Access Insight Brief

    Podcast — May 30, 2012
    Insight Briefing series on Market Access in key European countries

  • Nordic Region Market Access

    Presentation — May 22, 2012
    The countries of the Nordic region are, together, one of the most important pharmaceutical marketplaces in Europe. Their significance is due to their combined size,

  • Demonstrating Value Driving Commercial Success

    Brochure — May 17, 2012
    Global Market Access and Commercialization, a core practice from Consulting at Quintiles, stands ready to help you navigate the value substantiation process, from developing and demonstrating your product’s value platform to assisting in winning a preferred position on payer formularies and negotiating favorable pricing and reimbursement.

  • Cancer Treatments and the Search for Value

    White Paper — April 2, 2012
    Cancer Treatment and the Search for Value In September 2011, The Economist Intelligence Unit surveyed 399 senior executives from the life sciences industry and payer

  • Quintiles Forms New Biomarker Research and Development Company

    Press Release — January 18, 2012 – Quintiles announced that it has invested in a new company formed to provide oncology consulting services and new cancer biomarkers, the key to scientific selection of the right drug for the right patient.

  • ISPOR Europe 2012

    Event — Conference Date(s): November 3 - November 7, 2012
    Location: Berlin, German

  • ISPOR US 2012

    Event — Conference Date(s): June 2 - June 6, 2012
    Location: Washington, DC

Page 1 of 6 (57 results)

Subscribe to Email Based on Your Interests

Set preferences